InspireMD (NSPR) EBT Margin (2010 - 2025)
InspireMD's (NSPR) quarterly EBT Margin came in at 2402.41% in Q4 2025, up 56306.0% year-on-year from N/an in Q4 2024, and down 364.43% quarter-over-quarter from 517.28% in Q3 2025.
InspireMD (NSPR) EBT Margin (2010 - 2025) Analysis & Trends
InspireMD's EBT Margin history runs 16 years deep, the most recent figure standing at 2402.41% for Q4 2025.
- On a quarterly basis, EBT Margin rose 56306.0% year-over-year to 2402.41% in Q4 2025; TTM through Dec 2025 was 1260.52%, a 9155.0% decrease from a year earlier, with the FY2025 full-year figure at 542.63%, down 8685.0% from the prior year.
- EBT Margin retreated to 2402.41% in Q4 2025 per NSPR's latest filing, from 517.28% in the prior quarter.
- Across five years, EBT Margin topped out at 293.62% in Q4 2021 and bottomed at 2965.47% in Q4 2024.
- The 5-year median for EBT Margin is 423.81% (2021), against an average of 680.11%.
- Across the five-year window, EBT Margin soared 2430321 bps in 2021 and tumbled 200346 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 293.62% in 2021, then plunged by 60 bps to 469.49% in 2022, then sank by 105 bps to 962.01% in 2023, then slumped by 208 bps to 2965.47% in 2024, then climbed by 19 bps to 2402.41% in 2025.
- Per Business Quant, the three latest NSPR EBT Margin figures stand at 2402.41% (Q4 2025), 517.28% (Q3 2025), and 732.23% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | -2,402.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,402.41% |
| Sep 30, 2025 | -517.28% |
| Jun 30, 2025 | -732.23% |
| Mar 31, 2025 | -749.51% |
| Dec 31, 2024 | -2,965.47% |
| Sep 30, 2024 | -467.51% |
| Jun 30, 2024 | -474.99% |
| Mar 31, 2024 | -490.67% |
| Dec 31, 2023 | -962.01% |
| Sep 30, 2023 | -362.66% |
| Jun 30, 2023 | -322.32% |
| Mar 31, 2023 | -353.59% |
| Dec 31, 2022 | -469.49% |
| Sep 30, 2022 | -316.49% |
| Jun 30, 2022 | -302.81% |
| Mar 31, 2022 | -378.78% |
| Dec 31, 2021 | -293.62% |
| Sep 30, 2021 | -380.11% |
| Jun 30, 2021 | -337.86% |
| Mar 31, 2021 | -322.37% |